ARC
KERX

Absolute Return Capital’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Absolute Return Capital’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-171,546
Closed -$604K – 423
2015
Q3 		$604K Sell
171,546
-1,263
-0.7% -$8.46K 0.04% 346
2015
Q2 		$1.73M Buy
172,809
+15,721
+10% +$169K 0.07% 281
2015
Q1 		$2M Buy
157,088
+47,229
+43% +$607K 0.05% 300
2014
Q4 		$1.55M Buy
109,859
+16,935
+18% +$262K 0.03% 387
2014
Q3 		$1.28M Buy
92,924
+6,344
+7% +$97.1K 0.02% 493
2014
Q2 		$1.33M Buy
+86,580
New +$1.23M 0.02% 635

Other funds holding KERX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
CCP
Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Absolute Return Capital's KERX Position: Q4 2015 in Review

Absolute Return Capital sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2015, closing a stake of 171,546 shares — an estimated $604K sold.

Absolute Return Capital first reported a position in KERX in Q2 2014 and held it in 6 quarters. The position peaked at $2M in Q1 2015. 128 funds tracked by Wall St. Rank hold KERX as of Q4 2015.

  • Absolute Return Capital reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2015 after selling out during the quarter.
  • Absolute Return Capital sold 171,546 Keryx Biopharmaceuticals Inc shares in Q4 2015, an estimated $604K.
  • Absolute Return Capital first reported a position in Keryx Biopharmaceuticals Inc in Q2 2014 and held it in 6 quarters.
  • Absolute Return Capital's Keryx Biopharmaceuticals Inc position peaked at $2M in Q1 2015.
  • 128 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2015.

Based on Absolute Return Capital's 13F filing for Q4 2015.